Ambarella, Inc. (NASDAQ:AMBA - Get Free Report) saw an uptick in trading volume on Tuesday . 1,804,822 shares were traded during mid-day trading, an increase of 148% from the previous session's volume of 728,073 shares.The stock last traded at $59.75 and had previously closed at $51.57.
Analyst Upgrades and Downgrades
Several equities analysts have weighed in on the stock. Summit Insights raised shares of Ambarella to a "hold" rating in a report on Thursday, May 29th. Stifel Nicolaus decreased their target price on shares of Ambarella from $100.00 to $80.00 and set a "buy" rating on the stock in a research report on Thursday, April 17th. Wall Street Zen raised shares of Ambarella from a "sell" rating to a "hold" rating in a research note on Friday, February 28th. Needham & Company LLC dropped their price objective on Ambarella from $110.00 to $90.00 and set a "buy" rating for the company in a report on Friday, May 30th. Finally, Rosenblatt Securities upped their target price on shares of Ambarella from $87.00 to $95.00 and gave the stock a "buy" rating in a research note on Friday, May 30th. Five equities research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. According to MarketBeat, the company has an average rating of "Moderate Buy" and a consensus target price of $84.55.
View Our Latest Analysis on AMBA
Ambarella Stock Up 17.1%
The firm has a market capitalization of $2.56 billion, a PE ratio of -24.25 and a beta of 1.99. The business has a 50-day moving average price of $53.28 and a 200-day moving average price of $61.93.
Institutional Trading of Ambarella
A number of institutional investors and hedge funds have recently added to or reduced their stakes in AMBA. Vanguard Group Inc. raised its holdings in shares of Ambarella by 3.2% in the 1st quarter. Vanguard Group Inc. now owns 4,848,305 shares of the semiconductor company's stock valued at $244,015,000 after purchasing an additional 152,181 shares in the last quarter. The Manufacturers Life Insurance Company increased its holdings in Ambarella by 7.3% in the fourth quarter. The Manufacturers Life Insurance Company now owns 1,452,128 shares of the semiconductor company's stock valued at $105,628,000 after buying an additional 98,841 shares during the last quarter. Millennium Management LLC raised its stake in Ambarella by 11.5% in the fourth quarter. Millennium Management LLC now owns 1,394,192 shares of the semiconductor company's stock valued at $101,414,000 after buying an additional 144,268 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its holdings in Ambarella by 88.9% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,232,272 shares of the semiconductor company's stock worth $62,020,000 after buying an additional 579,917 shares during the last quarter. Finally, Fuller & Thaler Asset Management Inc. boosted its position in shares of Ambarella by 25.6% during the 1st quarter. Fuller & Thaler Asset Management Inc. now owns 910,911 shares of the semiconductor company's stock worth $45,846,000 after acquiring an additional 185,444 shares in the last quarter. Hedge funds and other institutional investors own 82.09% of the company's stock.
Ambarella Company Profile
(
Get Free Report)
Ambarella, Inc develops semiconductor solutions that enable high-definition (HD) and ultra HD compression, image signal processing, and artificial intelligence processing worldwide. The company's system-on-a-chip designs integrated HD video processing, image processing, artificial intelligence computer vision algorithms, audio processing, and system functions onto a single chip for delivering video and image quality, differentiated functionality, and low power consumption.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Ambarella, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ambarella wasn't on the list.
While Ambarella currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
